MedTrace Logo

Posterior Innominate Mobilization Versus Muscle Energy Technique on Lumbopelvic Angles in Sacroiliac Joint Dysfunction

NCT06280963 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-02-28

No results posted yet for this study

Summary

the goal of this clinical trial study is to compare between posterior innominate mobilization and muscle energy techniqueon lumbopelvic angles in sacroiliac joint dysfunction patients.

the main questions they aim to answer are

1. are there statistical significant effects of posterior innominate mobilization versus muscle energy technique on lumbopelvic angles in sacroiliac joint dysfunction patients ?
2. are there statistical significant effects of posterior innominate mobilization versus muscle energy technique on pain intensity level in sacroiliac joint dysfunction patients ?

* purpose of the study is to measure the effect of muscle energy technique versus posterior innominate mobilization on lumbopelvic angles in sacroiliac joint dysfunction

Conditions

  • Sacroiliac Joint Dysfunction

Interventions

BEHAVIORAL

muscle energy technique

in muscle energy technique, the target is gluteus maximus muscle ( hip extension ) and repeat the method from three to five times .

BEHAVIORAL

posterior innominate mobilization

in posterior innominate mobilization ( grade 3 mobilization ) , frequency of mobilizations is 30 oscillations , 3 sets per session ( every set has 30 oscillations )

BEHAVIORAL

conventional treatment

conventional treatment include * TENS ( 45 minutes of conventional TENS ) * Ultrasound (pulsed mode 1:1 ,5 min .1.5W/cm2 ) * Stretching exercises ( hamstrings ,hip flexors and hip adductors) * Strengthening exercises (lower abdomen and glutes muscles ) * Lumpopelvic stabilization exercise

Sponsors & Collaborators

  • Mahmoud Yousry Rashwan Hefny

    lead OTHER

Principal Investigators

  • Haytham M Elhafez · faculty of physical therapy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
FACTORIAL

Eligibility

Min Age
25 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-01
Primary Completion
2024-06-01
Completion
2024-08-03

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06280963 on ClinicalTrials.gov